PSYCHEMEDICS CORP (PMDI) — Inside-Filings

Kritische 8-K Meldungen

Datum	Meldung	Schwere	Filing	Auszug
26.01.2024	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMP
08.11.2023	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMP
22.09.2023	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	. ☐ ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICER
31.08.2023	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; CO
16.02.2023	Item 5.02 — Abgang Schlüsselpersonen	HOCH	SEC	Act. ☐ ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICER

Stammdaten

Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising aka K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Dallas, Texas.

Unternehmen & Branche

Name	PSYCHEMEDICS CORP
Ticker	PMDI
CIK	0000806517
Boerse	US
Sektor	Healthcare
Industrie	Diagnostics & Research
SIC	8071 · Services-Medical Laboratories

Wertpapier & Kennzahlen

CUSIP	–
ISIN	–
Typ	Common Stock

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Nettoergebnis	EPS	Aktiva	Eigenkapital
2024-12-31	10-K	-1,861,000		8,318,000	5,130,000
2024-09-30	10-Q	-535,000		9,835,000	5,446,000
2024-06-30	10-Q	-827,000		10,113,000	5,741,000
2024-03-31	10-Q	-688,000		11,152,000	6,281,000
2023-12-31	10-K	-4,154,000		12,326,000	6,672,000
2023-09-30	10-Q	-2,099,000	-0.36	14,104,000	7,429,000
2023-06-30	10-Q	-726,000	-0.13	16,386,000	9,127,000
2023-03-31	10-Q	-384,000	-0.07	17,907,000	10,166,000
2022-12-31	10-K	-1,084,000	-0.19	18,732,000	10,771,000
2022-09-30	10-Q	-97,000	-0.02	20,478,000	11,722,000
2022-06-30	10-Q	-338,000	-0.06	20,450,000	11,936,000
2022-03-31	10-Q	39,000	0.01	20,968,000	12,461,000
2021-12-31	10-K	-665,000	-0.12	21,552,000	12,243,000
2021-09-30	10-Q	739,000	0.13	23,633,000	14,027,000
2021-06-30	10-Q	134,000	0.02	24,587,000	13,115,000
2021-03-31	10-Q	83,000	0.01	24,380,000	12,812,000
2020-12-31	10-K	-543,000	-0.10	24,003,000	12,512,000
2020-09-30	10-K	-1,107,000	-0.20
2020-09-30	10-Q	-1,107,000	-0.20	23,980,000	12,942,000
2020-06-30	10-Q	-2,050,000	-0.37	25,776,000	13,924,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.